Miguel G. Madariaga

ORCID: 0000-0003-1753-9427
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Influenza Virus Research Studies
  • Viral Infections and Vectors
  • Mycobacterium research and diagnosis
  • Respiratory viral infections research
  • Bacillus and Francisella bacterial research
  • Tuberculosis Research and Epidemiology
  • Infections and bacterial resistance
  • Vector-borne infectious diseases
  • Infectious Diseases and Mycology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Yersinia bacterium, plague, ectoparasites research
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Parasite Biology and Host Interactions
  • Primary Care and Health Outcomes
  • Parasites and Host Interactions
  • Pneumonia and Respiratory Infections
  • Mosquito-borne diseases and control
  • Infectious Diseases and Tuberculosis
  • Antifungal resistance and susceptibility
  • Herpesvirus Infections and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Viral Infections and Outbreaks Research
  • HIV/AIDS Research and Interventions
  • Infection Control and Ventilation

Naples Anesthesia & Physician Associates
2022

Naples Community Hospital Healthcare System
2014-2021

GlaxoSmithKline (United States)
2012-2014

University of Nebraska Medical Center
2004-2009

University of Nebraska–Lincoln
2007

United States Department of Agriculture
2007

Agricultural Research Service
2007

John H. Stroger, Jr. Hospital of Cook County
2003-2006

Rush University Medical Center
2002-2006

University of New Mexico
2005

In this study (NCT00985088) we evaluated different formulations of an H1N1 2009 pandemic influenza vaccine that deliver various viral hemagglutinin (HA) doses with or without AS03 (a tocopherol-based oil-in-water adjuvant system).A total 1340 healthy subjects aged ≥18 years were randomized to receive 1 2 adjuvanted (3.75-μg HA/AS03(A) 1.9-μg HA/AS03(B)) nonadjuvanted formulation. Safety and immunogenicity (by hemagglutination-inhibition [HI] assay) after each dose 6 months are reported...

10.1093/infdis/jir641 article EN The Journal of Infectious Diseases 2012-02-07

The effectiveness of an infectious diseases (ID) consultation is dependent on adherence to the recommendations. To delineate factors that affect adherence, we conducted a prospective cohort study 465 consultations at 2 academic institutions in which evaluated process, patient and consultant characteristics, types recommendations, compliance with overall rate was 80%, 85% crucial Multivariate analysis revealed ID recommendations higher when were therapeutic instead diagnostic, they related...

10.1086/383315 article EN Clinical Infectious Diseases 2004-04-20

This study (NCT00979602) evaluated the immunogenicity and relative protective efficacy of one dose influenza A(H1N1)pdm09 vaccine with or without AS03 (an α-tocopherol oil-in-water emulsion based Adjuvant System).

10.1016/j.vaccine.2013.07.007 article EN cc-by-nc-nd Vaccine 2013-07-12

ABSTRACT Trichosporon inkin is one of six pathogenic species the genus and etiologic agent pubic white piedra. have been reported as a cause disseminated infections, particularly among immunosuppressed patients. We describe third case T. peritonitis associated with peritoneal dialysis first to be treated caspofungin.

10.1128/jcm.41.12.5827-5829.2003 article EN Journal of Clinical Microbiology 2003-12-01

Background. This phase 2/3, randomized, placebo-controlled, observer-blinded study assessed the immunogenicity, reactogenicity, and safety of an inactivated, split-virion H5N1 influenza vaccine (A/Indonesia/5/2005) in children aged 6 months through 17 years. Methods. Children received 2 doses 21 days apart, each containing 1.9 µg hemagglutinin AS03B adjuvant (5.93 mg α-tocopherol). The randomization ratio was 8:3 for to placebo, with equal allocation between 3 age strata (6–35 months, 3–8...

10.1093/infdis/jiu548 article EN cc-by-nc-nd The Journal of Infectious Diseases 2014-10-06

Stockpiling vaccine for deployment in the event of an influenza pandemic is important mitigation strategy. A necessary aspect stockpiling to determine shelf-life stored vaccine.In this Phase II, open-label study we assessed immunogenicity and safety H5N1 A/Indonesia/5/2005 adjuvanted with AS03A. The AS03A-H5N1 was prepared from bulk antigen that had been 4 years, adjuvant 2.5 years. Both were filled separate multi-dose vials within months use, on day vaccination, contents mixed....

10.1016/j.vaccine.2014.07.062 article EN cc-by-nc-nd Vaccine 2014-07-30

Physicians in postgraduate training are expected to learn research methods but how best achieve that curricular goal is unclear. This article describes a novel educational approach develop skills among infectious disease fellows. Five fellows and two faculty members participated collaborative project as vehicle for active, problem-based learning. During the learning experience several tasks with specific objectives were achieved. The authors evaluated weaknesses strengths of an program....

10.1080/01421590500138804 article EN Medical Teacher 2006-01-01

Human neurotrichinellosis is seldom reported. This likely the result of low incidence parasites from genus Trichinella in United States domestic food supply, as well difficulties diagnosing disease, especially when neither organism nor source infection are readily available. Although trichinellosis supplies has been decreasing for many years, a resurgence occurred cases derived consumption wild game. We report rare case and implicate game infection. These results suggest that clinicians...

10.4269/ajtmh.2007.77.347 article EN American Journal of Tropical Medicine and Hygiene 2007-08-01

Trichosporon fungemia is usually seen in neutropenic patients with underlying hematological malignancies. In this report we describe a fatal case of asahii non-neutropenic patient non-hematological malignancy. For 1 week the exhibited hematuria, weakness, easy fatigability and headaches. At admission she had anemia, renal failure evidence right hydronephrosis bladder wall masses as detected by CT scan. She did not have history tobacco abuse, contact urinary carcinogens or Schistosoma...

10.7883/yoken.jjid.2006.129 article EN Japanese Journal of Infectious Diseases 2006-04-28

Abstract COVID-19 infections have spread widely in Peru, causing severe societal and health impact. We describe the evolution of epidemics, reasons for high transmission way disease is diagnosed managed Andean country

10.1093/trstmh/trab074 article EN other-oa Transactions of the Royal Society of Tropical Medicine and Hygiene 2021-04-25
Coming Soon ...